Cargando…
Curcumin (a constituent of turmeric): New treatment option against COVID‐19
In late December 2019, the outbreak of respiratory illness emerged in Wuhan, China, and spreads worldwide. World Health Organization (WHO) named this disease severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) caused by a new member of beta coronaviruses. Several medications are prescribed...
Autores principales: | Babaei, Fatemeh, Nassiri‐Asl, Marjan, Hosseinzadeh, Hossein |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7590269/ https://www.ncbi.nlm.nih.gov/pubmed/33133525 http://dx.doi.org/10.1002/fsn3.1858 |
Ejemplares similares
-
Interaction of Medicinal Plants and Their Active Constituents With Potassium Ion Channels: A Systematic Review
por: Rajabian, Arezoo, et al.
Publicado: (2022) -
Review of the effects of vitexin in oxidative stress‐related diseases
por: Babaei, Fatemeh, et al.
Publicado: (2020) -
Effect of curcumin, the active constituent of turmeric, on penicillin-induced epileptiform activity in rats
por: Tamaddonfard, Esmaeal, et al.
Publicado: (2012) -
Anti-Hyperglycemic and Insulin Sensitizer Effects of Turmeric and Its Principle Constituent Curcumin
por: Ghorbani, Zeinab, et al.
Publicado: (2014) -
Anticonvulsant, sedative and muscle relaxant effects of carbenoxolone in mice
por: Hosseinzadeh, Hossein, et al.
Publicado: (2003)